GE HealthCare designed StarGuide GX for the radiopharma boom. Is SPECT/CT becoming treatment infrastructure?
GE HealthCare has moved StarGuide GX toward the U.S. market as radiopharmaceutical therapy expands beyond conventional nuclear medicine. The 4D CZT SPECT/CT system is designed to image across a wide energy range, including investigational alpha emitters, highlighting how the theranostics boom is creating demand not just for drugs but for quantitation, dosimetry and workflow infrastructure.